
### [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730)
**Label:** congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency

**Subclasses:** [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), 

**Corr. equiv. classes:** [OMIM:614279](http://purl.obolibrary.org/obo/OMIM_614279), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:443087](http://www.orpha.net/ORDO/Orphanet_443087), 

**Class expressions from DL-Learner:**

- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0100133](http://purl.obolibrary.org/obo/HP_0100133) (Abnormality of the pubic hair) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0011357](http://purl.obolibrary.org/obo/HP_0011357) (Abnormality of hair density) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0009888](http://purl.obolibrary.org/obo/HP_0009888) (Abnormality of secondary sexual hair) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0008070](http://purl.obolibrary.org/obo/HP_0008070) (Sparse hair) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0001595](http://purl.obolibrary.org/obo/HP_0001595) (Abnormality of the hair) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) and [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) 52.02%


